Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: A population-based study in Osaka, Japan

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages 128-132

  Ito, Yuri ^a   Nakayama, Tomio ^a   Tsukuma, Hideaki ^a   Miyashiro, Isao ^a   Ioka, Akiko ^a   Sugimoto, Tomoyuki ^b   Rachet, Bernard ^a,c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cancer survival; Cure model; Population based cancer registries; Stomach cancer

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ERROR; DISTANT METASTASIS; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERDIAGNOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL MODEL; STOMACH CANCER; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84858785765     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.12.008     Document Type: Article

References (31)

1. Matsuda T., Marugame T., Kamo K.I., Katanoda K., Ajiki W., Sobue T., et al. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2009, 39(12):850-858.
2. Ito Y., Ohno Y., Rachet B., Coleman M.P., Tsukuma H., Oshima A. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol 2007, 37(6):452-458.
3. Boag J. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J Royal Stat Soc Ser B: Methodological 1949, 11(1):15-53.
4. De Angelis R., Capocaccia R., Hakulinen T., Soderman B., Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999, 18(4):441-454.
5. Verdecchia A., De Angelis R., Capocaccia R., Sant M., Micheli A., Gatta G., et al. The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998, 77(3):322-329.
6. Lambert P.C. Modeling of the cure fraction in survival studies. Stata J 2007, 7(3):351-375.
7. Lambert P.C., Thompson J.R., Weston C.L., Dickman P.W. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007, 8(3):576-594.
8. Francisci S., Capocaccia R., Grande E., Santaquilani M., Simonetti A., Allemani C., et al. The cure of cancer: a European perspective. Eur J Cancer 2009, 45(6):1067-1079.
9. Tai P., Yu E., Cserni G., Vlastos G., Royce M., Kunkler I., et al. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer 2005, 5:48.
10. Rubin D.B. Multiple imputation for nonresponse in surveys 1987, John Wiley & Sons, New York.
11. Lambert P.C., Dickman P.W., Osterlund P., Andersson T., Sankila R., Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. Int J Cancer 2007, 121(9):2052-2059.
12. Woods L.M., Rachet B., Lambert P.C., Coleman M.P. 'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol 2009, 20(8):1331-1336.
13. National Cancer Centre Abridged life tables in Japan for 1962-2008 2009.
14. StataCorp Stata statistical software: release 11 2009, StataCorp LP, College Station, TX.
15. Esserman L., Shieh Y., Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009, 302(15):1685-1692.
16. Welch H.G., Albertsen P.C. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009, djp278.
17. Hamashima C., Shibuya D., Yamazaki H., Inoue K., Fukao A., Saito H., et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008, 38(4):259-267.
18. Ministry of Health, Labour and Welfare Comprehensive survey of living conditions of the people on health and welfare (H.16) 2004.
19. Lambert R., Guilloux A., Oshima A., Pompe-Kirn V., Bray F., Parkin M., et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 2002, 97(6):811-818.
20. Dassen A.E., Lemmens V.E., van de Poll-Franse L.V., Creemers G.J., Brenninkmeijer S.J., Lips D.J., et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010, 46(6):1101-1110.
21. Bouvier A.M., Sant M., Verdecchia A., Forman D., Damhuis R., Willem Coebergh J., et al. What reasons lie behind long-term survival differences for gastric cancer within Europe?. Eur J Cancer 2010, 46(6):1086-1092.
22. Verdecchia A., Mariotto A., Gatta G., Bustamante-Teixeira M.T., Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003, 39(11):1603-1609.
23. Bertuccio P., Chatenoud L., Levi F., Praud D., Ferlay J., Negri E., et al. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009, 125(3):666-673.
24. Sugiyama H., Nishi N., Sakata R., Kodama K. Trends in incidence of stomach cancer by subsite in Hiroshima city, Japan. Proc Annu Meet Japanese Soc Publ Health 2006, Supplement:611. [In Japanese].
25. Schlemper R.J., Itabashi M., Kato Y., Lewin K.J., Riddell R.H., Shimoda T., et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 1997, 349(9067):1725-1729.
26. Rugge M., Cassaro M., Farinati F., Di Mario F. Diagnosis of gastric carcinoma in Japan and western countries. Lancet 1997, 350(9075):448.
27. Stolte M. Diagnosis of gastric carcinoma in Japan and western countries. Lancet 1997, 350(9075):448.
28. Sakamoto J., Yasue M. Do Japanese statistics on gastric carcinoma need to be revised?. Lancet 1997, 349(9067):1711-1712.
29. Tsukuma H., Oshima A., Narahara H., Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 2000, 47(5):618-621.
30. Sato N., Ito Y., Ioka A., Tanaka M., Tsukuma H. Gender differences in stomach cancer survival in Osaka, Japan: analyses using relative survival model. Jpn J Clin Oncol 2009, 39(10):690-694.
31. Micheli A., Ciampichini R., Oberaigner W., Ciccolallo L., de Vries E., Izarzugaza I., et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009, 45(6):1017-1027.